Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells

被引:44
作者
Cai, Huawei [1 ]
Peng, Fangyu [1 ,2 ,3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
copper metabolism; copper chaperones; antioxidant-1; non-small cell lung carcinoma; RNA interference; cancer therapy; TARGETING CANCER METABOLISM; IDENTIFICATION; XENOGRAFTS; EXPRESSION; MICE;
D O I
10.3892/or.2013.2436
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Copper is required for cell proliferation and tumor angiogenesis. Cellular copper metabolism is regulated by a network of copper transporters and chaperones. Antioxidant-1 (ATOX1) is a cytosolic copper chaperone important for intracellular copper transport, which plays a role in the regulation of cell proliferation by functioning as a transcription factor in cell growth signal-transduction pathways. The present study aimed to explore the role of ATOX1 in the copper-related regulation of lung cancer cell proliferation by immunohistochemical (IHC) analysis of ATOX1 expression in non-small cell lung cancer (NSCLC) tissue samples and by assessing the effects of RNA interference (RNAi)-mediated knockdown of ATOX1 on copper-stimulated proliferation of NSCLC cells. Overexpression of ATOX1 was detected in NSCLC by IHC analysis of the tissue samples from patients diagnosed with NSCLC when compared with expression of ATOX1 in nonmalignant lung tissue samples. Knockdown of ATOX1 in the NSCLC cells transduced by a lentiviral vector encoding short hairpin RNA (shRNA) specific for ATOX1 was associated with reduction in copper-stimulated cell proliferation. These findings suggest that ATOX1 plays an important role in copper-stimulated proliferation of NSCLC cells and ATOX1 holds potential as a therapeutic target for lung cancer therapy targeting copper metabolism.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 30 条
[1]
Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[2]
Cheung BB, 2011, CURR CANCER DRUG TAR, V11, P826
[3]
The copper chaperone for superoxide dismutase [J].
Culotta, VC ;
Klomp, LWJ ;
Strain, J ;
Casareno, RLB ;
Krems, B ;
Gitlin, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23469-23472
[4]
DIEZ M, 1989, ONCOLOGY-BASEL, V46, P230
[5]
COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION [J].
Finney, Lydia ;
Vogt, Stefan ;
Fukai, Tohru ;
Glesne, David .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (01) :88-94
[6]
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression [J].
Goldberg, Michael S. ;
Sharp, Phillip A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (02) :217-224
[7]
Targeting glucose metabolism for cancer therapy [J].
Hamanaka, Robert B. ;
Chandel, Navdeep S. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (02) :211-215
[8]
Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation [J].
Itoh, Shinichi ;
Kim, Ha Won ;
Nakagawa, Osamu ;
Ozumi, Kiyoshi ;
Lessner, Susan M. ;
Aoki, Hiroki ;
Akram, Kamran ;
McKinney, Ronald D. ;
Ushio-Fukai, Masuko ;
Fukai, Tohru .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (14) :9157-9167
[9]
Targeting cancer metabolism - aiming at a tumour's sweet-spot [J].
Jones, Neil P. ;
Schulze, Almut .
DRUG DISCOVERY TODAY, 2012, 17 (5-6) :232-241
[10]
Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221